Blog

Neurosurgeons at Pacific Neuroscience Institute are among the world’s leaders in the minimally invasive removal of a type of benign brain tumor called a meningioma. In October 2020, a group of surgeons led by PNI cofounder Daniel F. Kelly, MD, published a paper describing excellent...

This year, seven of Pacific Neuroscience Institute Medical Group’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be...

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Meet Sheena Reddy: A woman honors her mother’s fight against glioblastoma cancer while helping others.

Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.

Technology apps give you power in cancer care In a terrible accident, astronaut Steve Austin was severely injured and rushed to a top-secret high-tech facility. In a government-sanctioned surgery, scientists and doctors worked around the clock using experimental technology to install a bionic arm, eye,...

SIGNIFICANCE Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in adults. Despite the advances in understanding the molecular mechanism underlying GBM tumorigenesis, most of the current targeted therapies are still ineffective and temozolomide (TMZ) has remained the cornerstone of GBM treatment. Treatment...

An excellent team of outstanding neurosurgeons at Pacific Neuroscience Institute’s Brain Tumor Center has reported on 129 minimally invasive supraorbital (SO) surgeries in a recent paper; the highly encouraging results of a retrospective study are discussed. Minimally Invasive Surgery for Removal of Brain and Skull...

Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells...